CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
6.36
0.95%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.16
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026207 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026207%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003985 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003985%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Verastem Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 6.3
Open* 6.27
1-Year Change* 1550%
Day's Range* 6.27 - 6.49
52 wk Range 3.87-15.18
Average Volume (10 days) 65.47K
Average Volume (3 months) 1.77M
Market Cap 158.68M
P/E Ratio -100.00K
Shares Outstanding 25.27M
Revenue N/A
EPS -4.04
Dividend (Yield %) N/A
Beta 0.54
Next Earnings Date Mar 12, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 28, 2023 6.30 -0.12 -1.87% 6.42 6.44 6.25
Nov 27, 2023 6.52 -0.22 -3.26% 6.74 6.74 6.47
Nov 24, 2023 6.61 0.33 5.25% 6.28 6.73 6.19
Nov 22, 2023 6.33 0.06 0.96% 6.27 6.38 6.11
Nov 21, 2023 6.25 0.01 0.16% 6.24 6.47 6.17
Nov 20, 2023 6.34 0.18 2.92% 6.16 6.39 6.12
Nov 17, 2023 6.23 0.35 5.95% 5.88 6.41 5.88
Nov 16, 2023 6.01 -0.06 -0.99% 6.07 6.30 5.87
Nov 15, 2023 6.11 -0.12 -1.93% 6.23 6.25 6.03
Nov 14, 2023 6.20 -0.06 -0.96% 6.26 6.61 6.04
Nov 13, 2023 6.30 0.11 1.78% 6.19 6.34 6.15
Nov 10, 2023 6.27 -0.21 -3.24% 6.48 6.65 5.97
Nov 9, 2023 6.57 -0.30 -4.37% 6.87 6.94 6.53
Nov 8, 2023 6.99 -0.13 -1.83% 7.12 7.15 6.69
Nov 7, 2023 7.02 0.41 6.20% 6.61 7.28 6.61
Nov 6, 2023 6.59 -0.10 -1.49% 6.69 6.89 6.50
Nov 3, 2023 6.80 0.33 5.10% 6.47 7.03 6.47
Nov 2, 2023 6.39 0.11 1.75% 6.28 6.45 6.19
Nov 1, 2023 6.27 0.04 0.64% 6.23 6.37 6.15
Oct 31, 2023 6.25 0.16 2.63% 6.09 6.44 6.07

Verastem Events

Time (UTC) Country Event
Tuesday, March 12, 2024

Time (UTC)

12:30

Country

US

Event

Q4 2023 Verastem Inc Earnings Release
Q4 2023 Verastem Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 2.596 2.053 88.516 17.456 26.718
Total Operating Expense 75.533 63.462 139.456 149.797 121.501
Selling/General/Admin. Expenses, Total 24.975 24.115 58.655 101.212 77.265
Research & Development 50.558 39.347 40.876 45.778 43.648
Operating Income -72.937 -61.409 -50.94 -132.341 -94.783
Interest Income (Expense), Net Non-Operating -0.922 -9.791 -15.279 -16.227 -3.207
Net Income Before Taxes -73.812 -71.2 -67.532 -149.209 -72.434
Net Income After Taxes -73.812 -71.2 -67.726 -149.209 -72.434
Net Income Before Extra. Items -73.812 -71.2 -67.726 -149.209 -72.434
Net Income -73.812 -71.2 -67.726 -149.209 -72.434
Income Available to Common Excl. Extra. Items -73.812 -71.2 -67.726 -149.209 -72.434
Income Available to Common Incl. Extra. Items -73.812 -71.2 -67.726 -149.209 -72.434
Diluted Net Income -73.812 -71.2 -67.726 -149.209 -72.434
Diluted Weighted Average Shares 16.1378 14.5332 12.777 6.21458 5.41328
Diluted EPS Excluding Extraordinary Items -4.57385 -4.89911 -5.30062 -24.0095 -13.3808
Diluted Normalized EPS -4.56709 -4.89636 -4.98623 -24.5244 -13.3808
Revenue 2.596 2.053 88.516 17.456 26.718
Cost of Revenue, Total 0 0 32.952 1.238 0.165
Gross Profit 2.596 2.053 55.564 16.218 26.553
Depreciation / Amortization 0 0 0.793 1.569 0.423
Other, Net 0.047 0 -1.313 -0.641 25.556
Unusual Expense (Income) 0 0 6.18
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 0 0 0 0 0
Revenue 0 0 0 0 0
Cost of Revenue, Total 0
Gross Profit 0
Total Operating Expense 20.292 19.344 16.846 17.709 21.402
Selling/General/Admin. Expenses, Total 7.399 7.329 6.106 6.421 6.514
Research & Development 12.893 12.015 10.74 11.288 14.888
Depreciation / Amortization 0
Operating Income -20.292 -19.344 -16.846 -17.709 -21.402
Interest Income (Expense), Net Non-Operating 0.001 0.207 0.045 -0.401 -0.556
Net Income Before Taxes -24.281 -15.714 -16.808 -18.09 -21.952
Net Income After Taxes -24.281 -15.714 -16.808 -18.09 -21.952
Net Income Before Extra. Items -24.281 -15.714 -16.808 -18.09 -21.952
Net Income -24.281 -15.714 -16.808 -18.09 -21.952
Income Available to Common Excl. Extra. Items -24.281 -15.714 -16.808 -18.09 -21.952
Income Available to Common Incl. Extra. Items -24.281 -15.714 -16.808 -18.09 -21.952
Diluted Net Income -24.281 -15.714 -16.808 -18.09 -21.952
Diluted Weighted Average Shares 17.732 16.7226 17.0516 16.4286 15.538
Diluted EPS Excluding Extraordinary Items -1.36933 -0.93969 -0.98571 -1.10113 -1.4128
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -1.36933 -0.93969 -0.97932 -1.10113 -1.4128
Other, Net -3.99 3.423 -0.007 0.02 0.006
Unusual Expense (Income) 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 92.87 105.74 144.938 84.961 253.259
Cash and Short Term Investments 87.894 100.256 141.226 75.506 249.653
Cash & Equivalents 74.933 21.252 67.782 43.514 129.867
Short Term Investments 12.961 79.004 73.444 31.992 119.786
Total Receivables, Net 0.031 0.516 0.239 2.524 0.306
Prepaid Expenses 4.945 4.968 3.473 3.835 2.973
Total Assets 95.05 108.662 154.349 145.046 277.236
Property/Plant/Equipment, Total - Net 1.881 2.512 3.142 4.024 1.369
Property/Plant/Equipment, Total - Gross 3.411 4.187 4.611 4.962 1.878
Accumulated Depreciation, Total -1.53 -1.675 -1.469 -0.938 -0.509
Other Long Term Assets, Total 0.299 0.41 0.274 36.053 1.031
Total Current Liabilities 21.663 18.59 17.093 29.89 37.077
Accounts Payable 4.901 2.302 1.875 9.655 10.253
Accrued Expenses 15.777 16.288 15.218 19.785 21.108
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0.71 0 0.45
Total Liabilities 47.659 21.103 39.075 137.872 152.937
Total Long Term Debt 24.526 0.249 19.051 103.623 114.737
Other Liabilities, Total 1.47 2.264 2.931 4.359 1.123
Total Equity 47.391 87.559 115.274 7.174 124.299
Common Stock 0.02 0.019 0.017 0.008 0.007
Additional Paid-In Capital 784.894 751.217 707.715 531.937 499.741
Retained Earnings (Accumulated Deficit) -737.523 -663.711 -592.511 -524.785 -375.576
Other Equity, Total 0 0.034 0.053 0.014 0.127
Total Liabilities & Shareholders’ Equity 95.05 108.662 154.349 145.046 277.236
Total Common Shares Outstanding 16.7111 15.4399 14.2041 6.67623 6.15025
Long Term Debt 24.526 0.249 19.051 103.623 114.737
Accounts Receivable - Trade, Net 0.031 0.516 0.239 2.524 0.306
Total Inventory 0 3.096 0.327
Intangibles, Net 0 20.008 21.577
Current Port. of LT Debt/Capital Leases 0.275 0 5.716
Long Term Investments 0 5.995
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 174.485 189.963 118.893 92.87 108.759
Cash and Short Term Investments 165.663 183.086 111.204 87.894 103.976
Cash & Equivalents 94.986 183.086 97.26 74.933 78.166
Short Term Investments 70.677 0 13.944 12.961 25.81
Total Receivables, Net 0 0.002 0 0.031 0.074
Accounts Receivable - Trade, Net 0 0.002 0 0.031 0.074
Prepaid Expenses 8.822 6.875 7.689 4.945 4.709
Total Assets 176.153 191.758 120.877 95.05 111.095
Property/Plant/Equipment, Total - Net 1.371 1.534 1.707 1.881 2.048
Long Term Investments
Other Long Term Assets, Total 0.297 0.261 0.277 0.299 0.288
Total Current Liabilities 23.812 20.787 22.359 21.663 21.873
Accounts Payable 5.118 4.553 4.903 4.901 5.359
Accrued Expenses 17.216 14.621 14.767 15.777 15.549
Notes Payable/Short Term Debt 0.146 0.579 1.004 0 0
Total Liabilities 71.814 69.008 66.693 47.659 48.222
Total Long Term Debt 39.911 39.739 39.574 24.526 24.667
Long Term Debt 39.911 39.739 39.574 24.526 24.667
Other Liabilities, Total 8.091 8.482 4.76 1.47 1.682
Total Equity 104.339 122.75 54.184 47.391 62.873
Common Stock 0.003 0.003 0.02 0.02 0.021
Additional Paid-In Capital 880.65 879.105 786.236 784.894 783.606
Retained Earnings (Accumulated Deficit) -797.522 -777.518 -753.237 -737.523 -720.715
Other Equity, Total 0.049 0.001 0.006 0 -0.039
Total Liabilities & Shareholders’ Equity 176.153 191.758 120.877 95.05 111.095
Total Common Shares Outstanding 25.265 25.242 16.7357 16.7111 17.5063
Other Current Liabilities, Total 1.035 0.744 1.403 0.71 0.965
Current Port. of LT Debt/Capital Leases 0.297 0.29 0.282 0.275
Redeemable Preferred Stock 21.159 21.159 21.159
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -73.812 -71.2 -67.726 -149.209 -72.434
Cash From Operating Activities -63.673 -53.502 -33.506 -138.518 -74.515
Cash From Operating Activities 0.118 0.206 0.531 0.429 0.996
Non-Cash Items 6.121 16.908 21.261 16.492 -17.15
Cash Interest Paid 1.536 1.007 5.126 12.424 2.107
Changes in Working Capital 3.9 0.584 11.635 -7.799 13.65
Cash From Investing Activities 66.185 0.087 -47.363 89.613 -138.377
Capital Expenditures 0 -0.196 -0.033 -0.007 -23.507
Other Investing Cash Flow Items, Total 66.185 0.283 -47.33 89.62 -114.87
Cash From Financing Activities 51.784 6.885 69.63 -2.441 261.162
Financing Cash Flow Items 0 -0.925 -2.048 -0.506
Issuance (Retirement) of Stock, Net 27.636 7.81 109.044 0.569 105.965
Issuance (Retirement) of Debt, Net 24.148 0 -37.366 -2.504 155.197
Net Change in Cash 54.296 -46.53 -11.239 -51.346 48.27
Amortization 0 0 0.793 1.569 0.423
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -15.714 -73.812 -57.004 -38.914 -16.962
Cash From Operating Activities -20.286 -63.673 -47.057 -31.975 -19.281
Cash From Operating Activities 0.03 0.118 0.089 0.059 0.03
Non-Cash Items -2.194 6.121 4.878 3.443 1.626
Cash Interest Paid 0
Changes in Working Capital -2.408 3.9 4.98 3.437 -3.975
Cash From Investing Activities -0.804 66.185 53.16 48.513 19.264
Capital Expenditures 0 0 0 0
Other Investing Cash Flow Items, Total -0.804 66.185 53.16 48.513 19.264
Cash From Financing Activities 44.05 51.784 51.784 26.16 25.452
Financing Cash Flow Items 1.004 0 0 0 0
Issuance (Retirement) of Stock, Net 28.128 27.636 27.636 2.012 0.68
Net Change in Cash 22.96 54.296 57.887 42.698 25.435
Amortization 0
Issuance (Retirement) of Debt, Net 14.918 24.148 24.148 24.148 24.772

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Verastem Company profile

Verastem
Industry: Bio Therapeutic Drugs

117 Kendrick St Ste 500
CAMBRIDGE
MASSACHUSETTS 02142
US

Income Statement

  • Annual
  • Quarterly

News

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023
GBP

UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

10:48, 21 November 2023

Gold Rises as Traders price-in Fed Rate Cuts

Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

13:17, 20 November 2023

People also watch

US100

16,018.30 Price
+0.040% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

2,046.73 Price
+0.250% 1D Chg, %
Long position overnight fee -0.0196%
Short position overnight fee 0.0114%
Overnight fee time 22:00 (UTC)
Spread 0.30

XRP/USD

0.61 Price
-0.560% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

BTC/USD

37,894.65 Price
-0.340% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading